Nisulid 100 mg
Nisulid 100 mg is a medicine authorised by Swissmedic under authorisation number 52001. The authorisation holder is Pierre Fabre Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 May 1992 and the authorisation is valid without a time limit. ATC code M01AX17 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 52001 |
|---|---|
| Name | Nisulid 100 mg |
| Full name | Nisulid 100 mg, Granulat |
| Authorisation holder | Pierre Fabre Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M01AX17 |
| First authorisation | 19 May 1992 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Nisulid 100 mg, Granulat | B | 19 May 1992 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 48 | 15 | Sachet(s) | M01AX17 | 07.10.1. | B |
| 56 | 30 | Sachet(s) | M01AX17 | 07.10.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Nisulid 100 mg authorised in Switzerland?
Yes. Nisulid 100 mg is authorised by Swissmedic under authorisation number 52001, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Nisulid 100 mg have?
Nisulid 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Nisulid 100 mg?
The authorisation holder is Pierre Fabre Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.